GBGopal Singh Bisht

Gopal Singh Bisht

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Gopal Singh Bisht has a total of 20 co-authors. Here are the top co-authors by number of shared publications:

  • Deepika Sharma

    Department of Bioinformatics, Biotechnology and Pharmacy, Jaypee University of Information Technology, Solan, India

    4 shared publications
  • Deepika Sharma

    Department of Pharmaceutical Sciences, School of Health Sciences and Technology (SOHST), UPES, Bidholi, Dehradun, Uttarakhand, India

    4 shared publications
  • Lalit Sharma

    Department of Pharmacology, School of Pharmaceutical Sciences, Shoolini University of Biotechnology and Management Sciences

    3 shared publications
  • Lalita Sharma

    Department of Biotechnology and Bioinformatics, Jaypee University of Information Technology, Waknaghat, India

    3 shared publications
  • Rahul Shrivastava

    Department of Biotechnology & Bioinformatics, Jaypee University of Information Technology, Waknaghat, Solan, India

    3 shared publications
  • Aditi Sharma

    School of Pharmaceutical Sciences, Shoolini University, Solan, Himachal Pradesh, Pin Code 173229, India

    2 shared publications

Latest Publications

  • Unveiling the Self-assembly and Therapeutic Efficacy of Antimicrobial Peptides SA4 Against Multidrug-Resistant A. baumannii

    by Lalita Sharma, Gopal Singh Bisht

    Infections linked to Acinetobacter baumannii are one of the main risks of modern medicine. Biofilms formed by A. baumannii due to a protective extracellular polysaccharide matrix make them highly tolerant to conventional antibiotics and raise the possibility of antibiotic resistance. Antimicrobial peptides (AMPs) are gaining popularity due to their broad-spectrum actions and key properties of peptide self-assembly, making them a promising alternative to antibiotics. Here, we demonstrate that 12-residue synthetic self-assembled peptide SA4 nanostructures have enough antibacterial action to prevent the growth of mature bacterial biofilms. The SA4 peptide was successfully synthesized by using the solid-phase peptide synthesis method, and its self-assembly was prepared in water. The self-assembled peptide hydrogel formed nanotube structure was observed under a scanning electron microscope and further characterized to confirm their physical and molecular properties. The resulting hydrogel exhibits significant antibacterial activity against MDR A. baumannii strains (MDR-1 and MDR-2), responsible for many nosocomial infections. In addition, at various gel concentrations, this hydrogel has the potential to inhibit about 30–80% of biofilms formed by MDR strains. Furthermore, under a microscope, it has been observed that the rupture of the bacterial cell membrane and cell wall of A. baumannii cells is caused by peptide nanotubes generated by self-assemblies. Thus, peptide-based nanotubes present intriguing avenues for various biomedical applications. This is the first report of bacterial biofilm removal with SA4 peptide nanotubes, and offering a unique treatment for infections linked to biofilms.


  • Recent Updates on Folate Targeted Drug Delivery Systems in Cancer: A Mini Review

    by Gopal Singh Bisht, Deepika Sharma, Manu Sharma

    Targeted drug delivery systems that selectively deliver anticancer drugs to tumour cells have always been a field of interest to reduce side effects associated with chemotherapy in cancer patients. Cancer cells require nutrients for their multiplication; folic acid is one such nutrient. Expression of folate receptors is negligible in normal cells, whereas they are overexpressed in a variety of cancer cells. A number of studies have shown that selective targeting of folate receptors in cancer is a beneficial approach, as folate targeted anticancer conjugates are selective towards cancer cells, thereby sparing non-cancerous cells. In this review, we have discussed folate receptor, folic acid as a cancer targeting moiety, different folate targeted anticancer drug conjugates, and different folate conjugated nanodelivery systems. This summarized information may turn out to be valuable for researchers to design novel folate targeted anticancer drug delivery systems having the potential to reduce the drawbacks associated with conventional cancer therapeutics.


  • Recent updates on folate targeted drug delivery systems in cancer: A minireview

    by Gopal Singh Bisht, Deepika Sharma, Manu Sharma

    Targeted drug delivery systems that selectively deliver anticancer drugs to tumour cells have always been a field of interest to reduce side effects associated with chemotherapy in cancer patients. Cancer cells require nutrients for their multiplication; folic acid is one such nutrient. Expression of folate receptors is negligible in normal cells, whereas they are overexpressed in a variety of cancer cells. A number of studies have shown that selective targeting of folate receptors in cancer is a beneficial approach, as folate targeted anticancer conjugates are selective towards cancer cells, thereby sparing non-cancerous cells. In this review, we have discussed folate receptor, folic acid as a cancer targeting moiety, different folate targeted anticancer drug conjugates, and different folate conjugated nanodelivery systems. This summarized information may turn out to be valuable for researchers to design novel folate targeted anticancer drug delivery systems having the potential to reduce the drawbacks associated with conventional cancer therapeutics.


  • Synergistic effects of short peptides and antibiotics against bacterial and fungal strains

    by Lalita Sharma, Gopal Singh Bisht

    There is a rising tide of concern about the antibiotic resistance issue. To reduce the possibility of antibiotic‐resistant infections, a new generation of antimicrobials must be developed. Antimicrobial peptides are potential alternatives to antibiotics that can be used alone or together with conventional antibiotics to combat antimicrobial resistance. In this work, lead compounds LP‐23, DP‐23, SA4, and SPO from previously published studies were synthesized by solid‐phase peptide synthesis and their antimicrobial evaluation was carried out against various bacterial and fungal strains. Peptide combinations with antibiotics were evaluated by using the checkerboard method and their minimal inhibitory concentration (MIC) in combination was calculated by using the fractional inhibitory concentration (FIC) index. Cytotoxicity evaluations of these peptides further confirmed their selectivity toward microbial cells. Based on the FIC values, LP‐23, DP‐23, and SPO demonstrated synergy in combination with gentamicin against a gentamicin‐resistant clinical isolate of Escherichia coli. For Staphylococcus aureus, Escherichia coli, and Salmonella typhimurium, seven combinations exhibited synergistic effects between peptide/peptoids and the tested antibiotics. Additionally, almost all the combinations of peptides/peptoids with amphotericin B and fluconazole also showed effective synergy against Aspergillus niger and Aspergillus flavus. The synergy found between LP‐23, DP‐23, SA4, and SPO with the selected antibiotics may have the potential to be used as a combination therapy against various microbial infections.


  • A Mini-review on Nanodelivery Systems as Therapeutics in Cancer

    by Gopal Singh Bisht, Deepika Sharma

    This review article gives a brief account of advances in the treatment of cancer via nanodelivery systems. We have discussed benefits of different nanocarriers that have the potential to deal with the problem of non-selectivity of conventional anticancer drugs. Targeted drug delivery not only spares healthy cells from harmful effects of anticancer drugs but also reduces the amount of drug to be administered; various drug delivery systems have been fabricated using appropriate nanocarriers. In fact, some carrier systems are biodegradable and degrade in the body into nontoxic moieties, thereby adding safety characteristics to the formulation. Selectivity towards cancer cells makes nanodelivery system a choice for the treatment of cancer as compared to conventional drug delivery. This review discusses various targeting strategies, different nanodelivery systems, characteristics required to be an ideal drug delivery system, advantages of these systems, and future prospects of such systems.

  • Open Access

    In‐silico and in‐vitro evaluation of imidazolone fused quinazolinone derivatives as anti‐amyloidal agents in Alzheimer’s

    by Lalit Sharma, Deepak Kumar, Gopal Singh Bisht

    Background: Alzheimer’s disease with a long preclinical period of ∼20 years is a chronic, insidious, and progressive neurodegenerative disease of old age. Neuropathologically AD is characterized by the presence of accumulated Amyloid‐beta in plaques (in extracellular spaces, and walls of blood vessels) and aggregated tau protein in neurofibrillary tangles. Quinazolinone derivatives exhibit inhibition to β‐secretase as well as its core quinazoline moiety prevents the cholinergic system from pathological activities of Aβ by possessing significant amount of inhibition.Method: In‐silico evaluation was based over computational approaches counting receptor and ligand preparation, grid formation, docking simulation, and its analysis followed by in‐vitro investigation via Thioflavin T‐amyloid binding assay and Protease (Trypsin) digestion assay.Result: The computational approach provides us with two molecules A and B with higher estimated free energy of binding whereas for the justification of in‐vitro test results one molecule J with lower estimated free energy of binding from top ten docked scored molecules was selected. In‐vitro investigation of these three compounds reveals that compound A cause significant (p1‐42 peptides resistance to tryptic digestion, when compared with control. Compound B possess lesser amount of reduction (p<0.005) in both the assays as compared to compound A whereas, activity of Compound J was found to be almost negligible.Conclusion: From the present study we found that our test compound A has shown significant results in modulating the Aβ aggregates i.e. Aβ fibrils. This study strongly suggests the further evaluation of this imidazolone fused quinazolinone derivative.


  • Recent Updates on Antifungal Peptides

    by Deepika Sharma, Gopal Singh Bisht

    The current trend of increment in the frequency of antifungal resistance has brought research into an era where new antifungal compounds with novel mechanisms of action are required. Natural antimicrobial peptides, which are ubiquitous components of innate immunity, represent their candidature for novel antifungal peptides. Various antifungal peptides have been isolated from different species ranging from small marine organisms to insects and from various other living species. Based on these peptides, various mimetics of antifungal peptides have also been synthesized using non-natural amino acids. Utilization of these antifungal peptides is somehow limited due to their toxic and unstable nature. This review discusses recent updates and future directions of antifungal peptides, for taking them to the shelf from the bench.